Susan L Kalled

USPTO Granted Patents = 15 (Patent Applications = 7)

CIPO Patents = 1

EPO Patents = 2 (Patent Applications = 2)

Average Co-Inventor Count = 2.5

ph-index = 5

Forward Citations = 107(Granted Patents)

Company Filing History:

where one patent can have more than one assignee

Years Active: 2010-2024

Loading Chart...

15 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11879008 - Methods of treating complement mediated diseases with fusion protein constructs comprising anti-C3d antibody and a complement modulator (2024-01-23),

2. 11111307 - Anti-BCMA antibodies (2021-09-07),

3. 11053306 - Fusion protein constructs comprising anti-C3d antibody and factor H (2021-07-06),

4. 11053305 - Fusion protein constructs comprising anti-C3d antibody and CR1 polypeptide (2021-07-06),

5. 9545086 - BAFF, inhibitors thereof and their use in the modulation of B-cell response and treatment of autoimmune disorders (2017-01-17),

6. 9387237 - Methods of treating a patient having an autoimmune disorder by administering a soluble BCMA (2016-07-12),

7. 9097726 - Methods of evaluating BAFF (2015-08-04),

8. 9034324 - Anti-BCMA antibodies (2015-05-19),

9. 8828948 - Method of treating a patient having an autoimmune disorder by administering BAFFR polypeptide (2014-09-09),

10. 8685657 - Methods of evaluating BAFF (2014-04-01),

11. 8617545 - Methods for use with BAFF antagonists (2013-12-31),

12. 8415111 - Methods of evaluating BAFF (2013-04-09),

13. 8202698 - Methods of evaluating BAFF (2012-06-19),

14. 8084030 - Method of treating a patient having an autoimmune disorder by administering an antibody that binds human BCMA (2011-12-27),

15. 7850967 - Method of treating a patient having an autoimmune disorder by administering an antibody that binds human BAFFR (2010-12-14),

Title: The Innovative Contributions of Susan L Kalled

Introduction

Susan L Kalled is a prominent inventor based in Concord, MA (US), known for her significant contributions to the field of biotechnology. With a remarkable portfolio of 15 patents, she has made strides in developing innovative treatments for various medical conditions. Her work primarily focuses on complement-mediated diseases and B cell-related disorders.

Latest Patents

Among her latest patents is a groundbreaking invention titled "Methods of treating complement mediated diseases with fusion protein constructs comprising anti-C3d antibody and a complement modulator." This invention provides fusion protein constructs that can bind to complement-associated antigens, which include a targeting moiety and a complement modulator protein. The targeting moiety can be an antibody or an antigen-binding fragment, and the methods outlined in this patent are aimed at treating conditions mediated by complement. Another notable patent is related to "Anti-BCMA antibodies," which recognizes the B Cell Maturation Antigen (BCMA). This invention offers antibodies that bind to naïve B cells, plasma cells, and memory B cells, along with methods for depleting these cells to treat B cell-related disorders, including lymphomas and autoimmune diseases.

Career Highlights

Throughout her career, Susan has worked with leading companies in the biotechnology sector, including Biogen Idec MA Inc. and Biogen MA Inc. Her experience in these organizations has allowed her to collaborate with some of the brightest minds in the industry, further enhancing her innovative capabilities.

Collaborations

Susan has collaborated with esteemed colleagues such as Yen-Ming Hsu and Sambasiva Rao, contributing to the advancement of research and development in her field.

Conclusion

Susan L Kalled's innovative work and dedication to biotechnology have led to significant advancements in medical treatments. Her patents reflect her commitment to addressing complex health issues, making her a valuable contributor to the scientific community.

This text is generated by artificial intelligence and may not be accurate.